Clinlogix, Now Part of NAMSA

Clinlogix, now part of NAMSA, is a global clinical research organization (CRO) based in Philadelphia. Founded in 1999, Clinlogix specializes in comprehensive clinical research services for medical device technologies. The company has supported over 500 clinical trials at more than 3,500 sites worldwide, focusing on areas such as cardiovascular, neurology, nephrology, urology, oncology, and venous/wound care. As part of NAMSA, Clinlogix enhances the organization's global reach and expertise in medical device development. NAMSA provides a wide range of services, including clinical trial management, preclinical laboratory testing, regulatory consulting, reimbursement strategies, and quality assurance. Clinlogix's offerings include end-to-end clinical trial management, extensive testing services to ensure device safety, and strategic guidance on regulatory and reimbursement pathways. Together, they support medical device manufacturers and sponsors in navigating the complexities of clinical development and regulatory compliance.

• Employees 17
• Founded 1999
• Annual Revenue $14078000